Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 38.15
-0.10 (-0.26%)
Oct 20, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 1.75 billion as of October 20, 2026. It is the 29,689th most valuable company in the world and the 1,751st biggest in Taiwan. Its market cap has increased by 12.87% in one year.
Market Cap
1.75B
Enterprise Value
2.15B
Revenue
650.87M
Global Rank
Country Rank
#1,751 Taiwan
PE Ratio
25.27
ChartMarket Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 1.75B, an increase of 127.40%. That is a compound annual growth rate of 3.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.75B | 23.06% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maywufa Company | 2.79B |
| Allied Biotech | 2.66B |
| Merdury Biopharmaceutical | 2.63B |
| PhytoHealth | 2.25B |
| TSH Biopharm Corporation | 2.16B |
| Johnson Chemical Pharmaceutical Works | 2.13B |
| GeneFerm Biotechnology | 1.21B |
| InnoPharmax | 1.13B |